Log in
Enquire now
‌

US Patent 11231401 Methods for detecting chromogranin a by mass spectrometry

Patent 11231401 was granted and assigned to Quest Diagnostics on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Quest Diagnostics
Quest Diagnostics
0
Current Assignee
Quest Diagnostics
Quest Diagnostics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112314010
Patent Inventor Names
Scott Goldman0
Michael McPhaul0
Michael P. Caufield0
Nigel Clarke0
Darren Weber0
Date of Patent
January 25, 2022
0
Patent Application Number
163553000
Date Filed
March 15, 2019
0
Patent Primary Examiner
‌
Jennifer Wecker
0
Patent abstract

Provided are methods for detecting chromogranin A by mass spectrometry. In another aspect, provided herein are methods for quantitating chromogranin A by mass spectrometry. In another aspect, provided herein are methods for prognosis of or measuring the size of neuroendocrine tumors by mass spectrometry.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11231401 Methods for detecting chromogranin a by mass spectrometry

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.